These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3884863)

  • 21. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological correction of disorders of the prostacyclin- thromboxane balance in ischemic heart disease: problems and prospects].
    Markov KhM
    Kardiologiia; 1990 Apr; 30(4):111-8. PubMed ID: 2118578
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of prostaglandins in the development of cardio- and hemodynamic disorders in postischemic shock].
    Sagach VF; Zhukova AV
    Fiziol Zh (1978); 1991; 37(2):25-31. PubMed ID: 1905243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating prostacyclin and thromboxane levels in patients with diabetic retinopathy.
    Lane LS; Jansen PD; Lahav M; Rudy C
    Ophthalmology; 1982 Jul; 89(7):763-6. PubMed ID: 6750495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luminal release of prostacyclin and thromboxane A2 by arteries distal to small-caliber prosthetic grafts.
    Bush HL; Jakubowski JA; Hong SL; McCabe M; Deykin D; Nabseth DC
    Circulation; 1984 Sep; 70(3 Pt 2):I11-5. PubMed ID: 6430592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without hereditary predisposition to ischemic heart disease].
    Akimov EV
    Kardiologiia; 1992 May; 32(5):41-3. PubMed ID: 1405259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists].
    Dzgoeva FU; Kutyrina IM
    Ter Arkh; 2000; 72(6):42-5. PubMed ID: 10900648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prostaglandins and ischemic cardiopathy].
    Strano A; Davì G
    Cardiologia; 1985 Apr; 30(4):261-4. PubMed ID: 3914359
    [No Abstract]   [Full Text] [Related]  

  • 29. Thromboxanes and ischaemic vascular disease.
    Hornstra G
    Neth J Med; 1982; 25(1):6-14. PubMed ID: 7035978
    [No Abstract]   [Full Text] [Related]  

  • 30. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
    Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB
    Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E1 reduces thromboxane A2 in hepatic ischemia-reperfusion.
    Hanazaki K; Kuroda T; Kajikawa S; Amano J
    Hepatogastroenterology; 2000; 47(33):807-11. PubMed ID: 10919036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of prostacyclin and thromboxane A2 in ischaemic heart disease.
    Neri Serneri GG; Gensini GF; Masotti G; Abbate R; Morettini A; Poggesi L; Fortini A
    Adv Exp Med Biol; 1984; 164():175-85. PubMed ID: 6364706
    [No Abstract]   [Full Text] [Related]  

  • 33. [The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
    Bakhoviddinova GSh
    Vrach Delo; 1991 Sep; (9):36-8. PubMed ID: 1759428
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of myocardial ischemia on prostacyclin and thromboxane levels in arterial and coronary venous blood].
    Vakhliaev VD; Meshcheriakova SA; Bol'shakova TD; Bogatyrev IV; Makolkin VI
    Kardiologiia; 1988 Mar; 28(3):41-5. PubMed ID: 3288802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostacyclin and thromboxane levels of children of parents suffering from early ischemic heart disease.
    Mihai K; Petó J; Kolthay E; Makáry A
    Acta Paediatr Hung; 1991; 31(1):113-8. PubMed ID: 1867870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental study of atherosclerosis. II. The effect of 8501 on the balance between thromboxane A2 and prostacyclin in preventing experimental atherosclerosis of rabbits].
    Wang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):421-5. PubMed ID: 2978398
    [No Abstract]   [Full Text] [Related]  

  • 37. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock.
    Sakanishi N; Tsunoda Y; Takekawa K; Ikezono E
    Bull Tokyo Med Dent Univ; 1983 Jun; 30(2):37-46. PubMed ID: 6580966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
    Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
    J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The prostacyclin-thromboxane A2 system in ischemic heart disease].
    Pavlov NA
    Sov Med; 1987; (2):36-9. PubMed ID: 3554549
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracavernosal kinetics of eicosanoids and endothelin during erection. Data from human and animal studies on intrapenile and systemic prostaglandins.
    Köhler H; Sohn M; Klein CL; Sikora R; Bosshardt R; Jakse G; Kirkpatrick CJ
    Int J Impot Res; 1993 Mar; 5(1):3-12. PubMed ID: 8348210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.